Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1964 1
1967 1
1969 2
1970 3
1971 1
1972 1
1976 1
1978 3
1979 2
1980 1
1981 5
1982 2
1983 2
1984 2
1985 1
1986 4
1987 1
1988 2
1989 2
1991 1
1992 2
1993 1
1994 2
1995 3
1996 7
1997 4
1998 10
1999 6
2000 8
2001 8
2002 13
2003 4
2004 7
2005 11
2006 12
2007 6
2008 9
2009 10
2010 20
2011 19
2012 14
2013 13
2014 16
2015 17
2016 25
2017 18
2018 11
2019 18
2020 22
2021 30
2022 24
2023 21
2024 16
2025 23
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

438 results

Results by year

Filters applied: . Clear all
Page 1
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Marfella R, Prattichizzo F, Sardu C, Paolisso P, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Ferraraccio F, Panarese I, Fanelli M, Modugno P, Calafiore AM, Melchionna M, Sasso FC, Furbatto F, D'Andrea D, Siniscalchi M, Mauro C, Cesaro A, Calabrò P, Santulli G, Balestrieri ML, Barbato E, Ceriello A, Paolisso G. Marfella R, et al. Among authors: fanelli m. Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29. Atherosclerosis. 2023. PMID: 37422356
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study.
Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, Triggiani D, Crudele L, Triggiani V, Sabbà C, De Pergola G, Piazzolla G. Volpe S, et al. Among authors: fanelli m. Front Endocrinol (Lausanne). 2023 Sep 13;14:1240263. doi: 10.3389/fendo.2023.1240263. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37780624 Free PMC article.
Distinct S-adenosylmethionine synthases link phosphatidylcholine to mitochondrial function and stress survival.
Munden AL, Mushtaq A, Lui DS, Edwards KM, Higgins DP, Biswas K, Walker RM, Crowley LH, Fanelli MJ, Ngyuen TK, Ericsson M, Godbole AA, Haley JA, Lewis CA, Spinelli JB, Harrison B, Raftery D, Djukovic D, Promislow DEL, Miller DL, Walker AK. Munden AL, et al. Among authors: fanelli mj. PLoS Biol. 2025 Dec 1;23(12):e3003075. doi: 10.1371/journal.pbio.3003075. eCollection 2025 Dec. PLoS Biol. 2025. PMID: 41325461 Free PMC article.
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study.
Vozza A, Triggiani D, Fanelli M, Lisco G, Coletto D, Custodero C, Volpe S, Racaniello D, Colaianni V, Lavarra V, Maggipinto R, Portacci A, Tortorella C, Moschetta A, Piazzolla G. Vozza A, et al. Among authors: fanelli m. Front Endocrinol (Lausanne). 2025 Sep 25;16:1674308. doi: 10.3389/fendo.2025.1674308. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 41079186 Free PMC article.
Thalidomide: a new anticancer drug?
Fanelli M, Sarmiento R, Gattuso D, Carillio G, Capaccetti B, Vacca A, Roccaro AM, Gasparini G. Fanelli M, et al. Expert Opin Investig Drugs. 2003 Jul;12(7):1211-25. doi: 10.1517/13543784.12.7.1211. Expert Opin Investig Drugs. 2003. PMID: 12831355 Review.
Advances in emerging drugs for osteosarcoma.
Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M. Hattinger CM, et al. Among authors: fanelli m. Expert Opin Emerg Drugs. 2015 Sep;20(3):495-514. doi: 10.1517/14728214.2015.1051965. Epub 2015 Jun 1. Expert Opin Emerg Drugs. 2015. PMID: 26021401 Review.
Antiangiogenic agents.
Stani SC, Capaccetti B, Bonginelli P, Sarmiento R, De Sio L, Fanelli M, Gasparini G. Stani SC, et al. Among authors: fanelli m. Suppl Tumori. 2002 Jul-Aug;1(4):S39-43. Suppl Tumori. 2002. PMID: 12415816 Review. No abstract available.
Revision Posterior Cruciate Ligament Surgery.
Fanelli GC, Fanelli MG, Fanelli DG. Fanelli GC, et al. Among authors: fanelli mg. Sports Med Arthrosc Rev. 2017 Mar;25(1):30-35. doi: 10.1097/JSA.0000000000000136. Sports Med Arthrosc Rev. 2017. PMID: 28045871 Review.
Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis.
Maiorano BA, Roviello G, Rizzo A, Ciccimarra F, Maruzzo M, Pierantoni F, Messina C, Messina M, Fanelli M, Veccia A, Rizzo M, Cavo A, Conteduca V, Chiuri VE, Cerbone L, Roberto M, Paolieri F, Galanti D, Spinelli GP, Mennitto A, Pisino M, Filippi R, Guadalupi V, Rocca MC, Sepe P, Fedele P, Dionese M, Secondino S, Rebuzzi SE, Vignani F, Sorarù M, Doronzo A, Catalano M, Gambale E, Santini D, Santoni M, Di Maio M, Antonuzzo L, Necchi A. Maiorano BA, et al. Among authors: fanelli m. Sci Rep. 2026 Jun 17;16(1):27711. doi: 10.1038/s41598-026-56672-6. Sci Rep. 2026. PMID: 42310334 Free PMC article.
New variants and genotype-phenotype correlation in KIF5A mutation: the contribution of a large Italian cohort.
Ferese R, Suppa A, Campopiano R, Scala S, Sammarone F, Di Pilla L, Di Pardo A, Chiaravalloti MA, Griguoli AM, Cannella M, D'Alessio C, Storto M, Fanelli M, Zampogna A, Patera M, Inghilleri M, Ceccanti M, Cambieri C, Buttari F, Peconi C, Giardina E, Zampatti S, Centonze D, Gambardella S. Ferese R, et al. Among authors: fanelli m. J Med Genet. 2025 Sep 19;62(10):641-646. doi: 10.1136/jmg-2025-110801. J Med Genet. 2025. PMID: 40562529 Free PMC article.
438 results